B. Riley Wealth Advisors’s Novavax NVAX Stock Holding History

B. Riley Wealth Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,104	Closed	-$302K	–	1467
2021 Q4	$302K	Buy	2,104 +95	+5%	+$16.3K	0.01%	1070
2021 Q3	$420K	Sell	2,009 -4,419	-69%	-$974K	0.01%	868
2021 Q2	$1.35M	Sell	6,428 -699	-10%	-$128K	0.04%	431
2021 Q1	$1.26M	Buy	7,127 +503	+8%	+$100K	0.04%	423
2020 Q4	$739K	Buy	6,624 +850	+15%	+$90.3K	0.04%	411
2020 Q3	$606K	Sell	5,774 -990	-15%	-$121K	0.03%	466
2020 Q2	$564K	Buy	+6,764	New	+$259K	0.04%	414
2015 Q1	–	Sell	-850	Closed	-$101	–	1500
2014 Q4	$101	Buy	850 +125	+17%	+$13.1K	﹤0.01%	1721
2014 Q3	$60K	Hold	725	–	–	0.02%	601
2014 Q2	$67K	Buy	725 +75	+12%	+$6.59K	0.02%	893
2014 Q1	$59K	Hold	650	–	–	0.02%	718
2013 Q4	$67K	Buy	650 +137	+27%	+$9.68K	0.02%	625
2013 Q3	$32K	Sell	513 -387	-43%	-$21.8K	0.01%	661
2013 Q2	$37K	Buy	+900	New	+$39K	0.01%	680

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

B. Riley Wealth Advisors's NVAX Position: Q1 2022 in Review

B. Riley Wealth Advisors sold out of Novavax (NVAX) in Q1 2022, closing a stake of 2,104 shares — an estimated $302K sold.

B. Riley Wealth Advisors first reported a position in NVAX in Q2 2013 and held it in 14 quarters. The position peaked at $1.35M in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

B. Riley Wealth Advisors reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
B. Riley Wealth Advisors sold 2,104 Novavax shares in Q1 2022, an estimated $302K.
B. Riley Wealth Advisors first reported a position in Novavax in Q2 2013 and held it in 14 quarters.
B. Riley Wealth Advisors's Novavax position peaked at $1.35M in Q2 2021.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2022, filed 2 May 2022.